In this study, however, Batar et al. reported that the combined XRCC1 AG/AA variant genotypes were associated with increased risk for ALL in females (OR = 5.47; 95% CI 1.49–20.10; p = 0.008) [34]. Here, XRCC1 is linked to acute lymphoblastic leukemia.